Evidence map›Paper›PMID 33278556›Full record

ArticleReproductive toxicology (Elmsford, N.Y.)2021

25th anniversary of the Berlin workshop on developmental toxicology: DevTox database update, challenges in risk assessment of developmental neurotoxicity and alternative methodologies in bone development and growth.

Philip Marx-Stoelting, Marize de L M Solano, Hiroaki Aoyama, Ralf H Adams, Anna Bal-Price, Jochen Buschmann, Ibrahim Chahoud, Ruth Clark, Tian Fang, Michio Fujiwara and 20 more

Open access · greenAbstract readLetter
In one paragraph

Article in Reproductive toxicology (Elmsford, N.Y.), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors at 19 institutions in 9 countries.

Philip Marx-StoeltingGerman Federal Institute for Risk Assessment, Berlin, Germany.
Marize de L M SolanoGerman Federal Institute for Risk Assessment, Berlin, Germany. Electronic address: devtox@bfr.bund.de.
Hiroaki AoyamaInstitute of Environmental Toxicology, Japan.
Ralf H AdamsMax Planck Institute for Molecular Biomedicine, Muenster, Germany.
Anna Bal-PriceEuropean Commission, Joint Research Centre (JRC), Ispra, Italy.
Jochen BuschmannPrivate Consultant, Hannover, Germany.
Ibrahim ChahoudCharité - Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität Zu Berlin, and Berlin Institute of Health, Germany.
Ruth ClarkRuth Clark Associates Ltd., United Kingdom.
Tian FangNHC Key Lab. of Reproduction Regulation (Shanghai Institute of Planned Parenthood Research), Fudan University, China.
Michio FujiwaraAstellas Pharma Inc., Tokyo, Japan.
Michael GelinskyTechnische Universität Dresden, Dresden, Germany.
Konstanze GroteCharité - Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität Zu Berlin, and Berlin Institute of Health, Germany.
Masao HorimotoChiba Institute of Science, Chiba, Japan.
Susanne Hougaard BennekouTechnical University of Denmark, Lyngby, Denmark.
Rupert KellnerFraunhofer Institute for Toxicology and Experimental Medicine, Hannover, Germany.
Makiko KuwagataNational Institute of Health Sciences, Kanagawa, Japan.
Marcel LeistUniversity of Konstanz, Konstanz, Germany.
Annemarie LangCharité - Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität Zu Berlin, and Berlin Institute of Health, Germany.
Weihua LiNHC Key Lab. of Reproduction Regulation (Shanghai Institute of Planned Parenthood Research), Fudan University, China.
Alberto MantovaniIstituto Superiore Di Sanità (ISS), Rome, Italy.
Susan L MakrisU.S. Environmental Protection Agency, Office of Research and Development, Center for Public Health and Environmental Assessment, Washington, D.C., USA.
Francisco PaumgarttenOswaldo Cruz Foundation, Brazil.
Monique PerronU.S. Environmental Protection Agency, Office of Pesticides Programs, Washington, D.C, USA.
Magdalini SachanaOrganisation for Economic Co-operation and Development (OECD), Environment Health and Safety Division, Paris, France.
Anne SchmittGerman Federal Institute for Risk Assessment, Berlin, Germany.
Steffen SchneiderBASF SE, Ludwigshafen, Germany.
Gilbert SchönfelderGerman Federal Institute for Risk Assessment, Berlin, Germany; Charité - Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität Zu Berlin, and Berlin Institute of Health, Germany.
Frank SchulzeGerman Federal Institute for Risk Assessment, Berlin, Germany.
Kohei ShiotaKyoto University, Kyoto, Japan.
Roland SoleckiGerman Federal Institute for Risk Assessment, Berlin, Germany.
Federal Institute for Risk Assessment · DEFreie Universität Berlin · DEAstellas Pharma (Japan) · JPBASF (Germany) · DEChiba Institute of Science · JPEnvironmental Protection Agency · USFraunhofer Institute for Toxicology and Experimental Medicine · DEFudan University · CNFundação Oswaldo Cruz · BRHumboldt-Universität zu Berlin · DEIstituto Superiore di Sanità · ITJoint Research Centre · ITMax Planck Institute for Molecular Biomedicine · DEMore Associates · GBNational Institute of Health Sciences · JPShanghai Institute of Planned Parenthood Research · CNTechnical University of Denmark · DKTU Dresden · DEUniversity of Konstanz · DE

Funding

Intramural EPA EPA999999
6 · The paper itself

Abstract

25 years after the first Berlin Workshop on Developmental Toxicity this 10th Berlin Workshop aimed to bring together international experts from authorities, academia and industry to consider scientific, methodologic and regulatory aspects in risk assessment of developmental toxicity and to debate alternative strategies in testing developmental effects in the future. Proposals for improvement of the categorization of developmental effects were discussed as well as the update of the DevTox database as valuable tool for harmonization. The development of adverse outcome pathways relevant to developmental neurotoxicity (DNT) was debated as a fundamental improvement to guide the screening and testing for DNT using alternatives to animal methods. A further focus was the implementation of an in vitro mechanism-based battery, which can support various regulatory applications associated with the assessment of chemicals and mixtures. More interdisciplinary and translation research should be initiated to accelerate the development of new technologies to test developmental toxicity. Technologies in the pipeline are (i) high throughput imaging techniques, (ii) models for DNT screening tests, (iii) use of computer tomography for assessment of thoracolumbar supernumerary ribs in animal models, and (iv) 3D biofabrication of bone development and regeneration tissue models. In addition, increased collaboration with the medical community was suggested to improve the relevance of test results to humans and identify more clinically relevant endpoints. Finally, the participants agreed that this conference facilitated better understanding innovative approaches that can be useful for the identification of developmental health risks due to exposure to chemical substances.

Indexed as

EducationAnniversaries and Special EventsBerlinBone DevelopmentInternet UseNervous SystemNervous System DiseasesRisk AssessmentToxicologyAlternative methodsBone formationDevTox-projectGrey zone anomaliesNeurodevelopmental toxicology testingRisk assessment

Identifiers

PMID33278556
PMCPMC9337270
OpenAlexW3109121673

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.